Biosimilar infliximab in real-life Crohn's disease's anti-TNFalfa naive patients: a comparative observational cohort study (SIMRECRO study)

被引：0
|
作者：
Carvalho Lourenco, L. [1 ]
Anapaz, V. [1 ]
Oliveira, A. M. [1 ]
Branco, J. [1 ]
Cardoso, M. [1 ]
Graca Rodrigues, C. [1 ]
Santos, L. [1 ]
Horta, D. [1 ]
Martins, A. [1 ]
Reis, J. [1 ]
机构：
[1] Hosp Prof Dr Fernando Fonseca, Serv Gastrenterol, Amadora, Portugal
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P327
引用
收藏
页码：S259 / S259
页数：1
相关论文
共 50 条
  • [1] Biosimilar infliximab in real-life Crohn's disease treatment in anti-TNF-alpha naive and non-naive patients in comparison to biologic originator: a comparative observational cohort study
    Kaniewska, M.
    Moniuszko, A.
    Maciejewska, K.
    Rydzewska, G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S292 - S293
  • [2] BIOSIMILAR INFLIXIMAB IN REAL-LIFE CROHN'S DISEASE TREATMENT IN ANTI-TNF-ALFA NAIVE AND NON-NAIVE PATIENTS IN COMPARISON TO BIOLOGIC ORIGINATOR: A COMPARATIVE OBSERVATIONAL COHORT STUDY
    Kaniewska, Magadalena A.
    Moniuszko, Andrzej
    Maciejewska, Katarzyna
    Rydzewska, Grazyna
    GASTROENTEROLOGY, 2017, 152 (05) : S586 - S587
  • [3] INFLIXIMAB ORIGINATOR, INFLIXIMAB BIOSIMILAR AND ADALIMUMAB ARE EQUALLY EFFECTIVE AND SAFE IN ULCERATIVE COLITIS AND CROHN'S DISEASE - A REAL-LIFE COHORT STUDY
    Barberio, B.
    Zingone, F.
    D'Inca, R.
    Rovigo, L.
    Marinelli, C.
    Massimi, D.
    Gubbiotti, A.
    Ghisa, M.
    Lorenzon, G.
    Savarino, E.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S130 - S131
  • [4] Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
    Barberio, Brigida
    Zingone, Fabiana
    D'Inca, Renata
    Rovigo, Laura
    Bertani, Lorenzo
    Bodini, Giorgia
    Ghisa, Matteo
    Gubbiotti, Alessandro
    Massimi, Davide
    Lorenzon, Greta
    Savarino, Edoardo Vincenzo
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11
  • [5] Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study from Finland
    Eberl, A.
    Hallinen, T.
    af Bjorkesten, C. -G.
    Heikkinen, M.
    Hirsi, E.
    Kellokumpu, M.
    Koskinen, I.
    Moilanen, V.
    Nielsen, C.
    Nuutinen, H.
    Suhonen, U. -M.
    Utriainen, K.
    Vihriala, I.
    Soini, E.
    Wennerstrom, C.
    Nissinen, R.
    Borsi, A.
    Koivunen, M.
    Tillonen, J.
    Sipponen, T.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S415 - S416
  • [6] Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study (ICC case series)
    Biemans, V.
    van der Meulen-de Jong, A.
    van der Woude, C.
    de Boer, N.
    Dijkstra, G.
    Oldenburg, B.
    Ponsioen, C.
    Maljaars, P.
    Haans, J.
    Pierik, M.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S55 - S56
  • [7] USTEKINUMAB FOR CROHN'S DISEASE: A NATIONWIDE REAL-LIFE OBSERVATIONAL COHORT STUDY (ICC CASE SERIES)
    Biemans, Vince
    Van der Meulen, Andrea
    Van der Woude, Christien Janneke
    de Boer, Nanne
    Dijkstra, Gerard
    Oldenburg, Bas
    Ponsioen, Cyriel
    Maljaars, Jeroen
    Haans, Jeoffrey
    Pierik, Marie
    Hoentjen, Frank
    GASTROENTEROLOGY, 2018, 154 (06) : S842 - S843
  • [8] Effectiveness and safety of biosimilar infliximab (remsima) in a real-life setting in 84 patients with Crohn's disease and ulcerative colitis
    Gheorghe, C.
    Svoboda, P.
    Dimitriu, A.
    Mateescu, B.
    Kotzev, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S316 - S317
  • [9] Biosimilar infliximab versus originator in Crohn's disease anti-TNF-α naive and non-naive patients
    Kaniewska, Magdalena
    Rosolowski, Mariusz
    Moniuszko, Andrzej
    Rydzewska, Grazyna
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2021, 16 (03): : 207 - 212
  • [10] The Real-Life Experience of Vedolizumab Efficacy and Safety in Crohn's Disease: A Prospective Observational Multicenter Cohort Study
    Amiot, Aurelien
    Grimaud, Jean-charles
    Treton, Xavier
    Filippi, Jerome
    Pariente, Benjamin
    Peyrin-Biroulet, Laurent
    Boureille, Arnaud
    Buisson, Anthony
    Carbonnel, Franck
    Bourrier, Anne
    Nancey, Stephane
    Roblin, Xavier
    Marteau, Philippe R.
    Altwegg, Romain
    Moreau, Jacques
    Aubourg, Alexandre
    Savoye, Guillaume
    Pelletier, Anne Laure
    Fumery, Mathurin
    Bonaz, Bruno L.
    Bouhnik, Yoram
    GASTROENTEROLOGY, 2016, 150 (04) : S810 - S810
12345